| Code | Description | Claims | Beneficiaries | Total Paid |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
14,455 |
13,581 |
$2.72M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
14,078 |
12,764 |
$2.08M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,606 |
6,156 |
$505K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
4,637 |
1,972 |
$257K |
| A0425 |
Ground mileage, per statute mile |
1,076 |
900 |
$218K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
603 |
516 |
$184K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,133 |
1,062 |
$131K |
| 36415 |
Collection of venous blood by venipuncture |
2,875 |
2,362 |
$103K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,873 |
6,048 |
$96K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
695 |
653 |
$82K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
196 |
182 |
$74K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
676 |
508 |
$61K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
329 |
119 |
$45K |
| 80053 |
Comprehensive metabolic panel |
1,937 |
1,672 |
$26K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
181 |
129 |
$20K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
110 |
103 |
$19K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
719 |
649 |
$14K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
164 |
108 |
$10K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
135 |
127 |
$9K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
287 |
259 |
$8K |
| 90832 |
Psychotherapy, 30 minutes with patient |
164 |
62 |
$8K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
313 |
284 |
$8K |
| J3490 |
Unclassified drugs |
755 |
445 |
$7K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
37 |
26 |
$6K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
15 |
12 |
$6K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
1,111 |
996 |
$5K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
357 |
333 |
$4K |
| 97602 |
|
127 |
62 |
$4K |
| 71045 |
Radiologic examination, chest; single view |
82 |
77 |
$4K |
| 71046 |
Radiologic examination, chest; 2 views |
53 |
53 |
$4K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
43 |
37 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
42 |
39 |
$2K |
| 81001 |
|
195 |
185 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
541 |
258 |
$2K |
| 36592 |
|
27 |
25 |
$1K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
67 |
60 |
$1K |
| 83605 |
|
108 |
88 |
$1K |
| 84484 |
|
42 |
36 |
$635.86 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
85 |
81 |
$624.07 |
| 86140 |
|
62 |
52 |
$600.08 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
98 |
94 |
$303.77 |
| J2704 |
Injection, propofol, 10 mg |
41 |
36 |
$300.51 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
34 |
24 |
$265.20 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
13 |
13 |
$240.32 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
56 |
48 |
$182.59 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
42 |
36 |
$152.64 |
| 81003 |
|
46 |
41 |
$105.98 |
| 81025 |
|
29 |
28 |
$88.54 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
26 |
25 |
$42.32 |
| A9270 |
Non-covered item or service |
65 |
53 |
$28.06 |
| J7050 |
Infusion, normal saline solution, 250 cc |
17 |
13 |
$20.88 |